← Evidence map

SynthesisDrug safety2004

A benefit-risk assessment of basiliximab in renal transplantation.

Ugo Boggi et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

7 papers cite it

2004

2005

2006

2007

2008

2009

2010

2011

2012

2013

2014

2015

2016

2017

2018

2019

2020

2021

2022

2023

this paperpooled itcites it

A benefit-risk assessment of basiliximab in renal transplantation. | OpenQuestion